Not applicableLooking for participantsNCT06659120
What this trial is testing
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Who this might be right for
Menstrual Migraine
Insel Gruppe AG, University Hospital Bern 120
Showing 11 of 11 results